Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase

Eur J Med Chem. 2018 Sep 5:157:852-866. doi: 10.1016/j.ejmech.2018.08.033. Epub 2018 Aug 16.

Abstract

The flavoenzyme dihydroorotate dehydrogenase (DHODH) catalyzes the fourth reaction of the de novo pyrimidine biosynthetic pathway, which exerts vital functions in the cells, especially within DNA and RNA biosynthesis. Thus, this enzyme stands out as a new key molecular target for parasites causing Neglected Diseases (NDs). Focused on contributing to the development of new therapeutic alternatives for NDs, in this study, for the first time, a screening of 57 natural products for in vitro inhibition of Leishmania major DHODH (LmDHODH) was carried out, including cross validation against the human DHODH (HsDHODH). A subset of natural products consisting of 21 sesquiterpene lactones (STLs) was submitted to QSAR studies. Additionally, thermostability studies by differential scanning fluorimetry (DSF) were performed to determine whether the STLs are effectively or not binding to the enzyme. The IC50 values against LmDHODH varied from 27 to 1200 μM; only irrelevant inhibition was obtained on HsDHODH. DSF assays confirmed binding of STLs to LmDHODH; moreover, it is suggested that such inhibitors might act in a different site other than the active site. A reliable QSAR model based on molecular descriptors was obtained (R2: 0.83; Q2CV: 0.69 and Q2EXT/F2: 0.66) indicating that stronger inhibition requires a balanced distribution of the hydrophobic regions across the molecular surface, as well as higher width and lower hydrophobicity of the molecules. A pharmacophore-based 3D-QSAR approach also afforded a useful model (R2: 0.72; Q2CV: 0.50 and Q2EXT/F2: 0.62), which confirmed the importance of proper orientation of the ligands, molecular surface features and shape for stronger inhibition, reflecting properties of a putative common binding site. These data indicated for the first time that natural products can actually inhibit LmDHODH and highlighted some metabolites as potentially interesting starting points for the discovery of more potent LmDHODH inhibitors, ultimately aiming at new effective therapeutic alternatives for leishmaniasis and, possibly, other NDs caused by trypanosomatids.

Keywords: Asteraceae; Dihydroorotate dehydrogenase; Leishmania major; Neglected diseases; Quantitative structure-activity relationships; Sesquiterpene lactones.

MeSH terms

  • Biological Products / chemistry
  • Biological Products / pharmacology*
  • Calorimetry, Differential Scanning
  • Dihydroorotate Dehydrogenase
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Lactones / chemistry
  • Lactones / pharmacology*
  • Leishmania major / enzymology*
  • Models, Molecular
  • Molecular Structure
  • Oxidoreductases Acting on CH-CH Group Donors / antagonists & inhibitors*
  • Oxidoreductases Acting on CH-CH Group Donors / metabolism
  • Quantitative Structure-Activity Relationship
  • Sesquiterpenes / chemistry
  • Sesquiterpenes / pharmacology*

Substances

  • Biological Products
  • Dihydroorotate Dehydrogenase
  • Enzyme Inhibitors
  • Lactones
  • Sesquiterpenes
  • Oxidoreductases Acting on CH-CH Group Donors